{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:28:26Z","timestamp":1769578106519,"version":"3.49.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jiac.2023.02.015","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T20:34:07Z","timestamp":1677875647000},"page":"599-603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single-center survey of prescription trends and appropriate use plans for macrolide antimicrobials"],"prefix":"10.1016","volume":"29","author":[{"given":"Tomoyuki","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8085-4940","authenticated-orcid":false,"given":"Masayuki","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ippei","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Seyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Sekikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiori","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2023.02.015_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1473-3099(19)30039-8","article-title":"Macrolide resistance in Streptococcus spp","volume":"3","author":"Tsuzuki","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2023.02.015_bib2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fcimb.2016.00098","article-title":"Macrolide resistance in Streptococcus pneumoniae","volume":"6","author":"Schroeder","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jiac.2023.02.015_bib3","series-title":"Japan nosocomial infections surveillance (JANIS)","year":"2021"},{"key":"10.1016\/j.jiac.2023.02.015_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10156-007-0528-5","article-title":"High prevalence of erythromycin resistance and macrolide-resistance genes, mefA and ermB, in Streptococcus pneumoniae isolates from the upper respiratory tracts of children in the Sapporo district","volume":"4","author":"Harimaya","year":"2007","journal-title":"Jpn J Infect Chemother."},{"key":"10.1016\/j.jiac.2023.02.015_bib8","doi-asserted-by":"crossref","unstructured":"Blasi F, Mantero M, Aliberti S. Antibiotics as immunomodulant agents in COPD. Curr Opin Pharmacol 201;3:293-299.","DOI":"10.1016\/j.coph.2012.01.006"},{"issue":"3","key":"10.1016\/j.jiac.2023.02.015_bib9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pharmthera.2007.11.001","article-title":"Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action","volume":"117","author":"Shinkai","year":"2008","journal-title":"Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.jiac.2023.02.015_bib10","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2023.02.015_bib11","first-page":"CD012406","article-title":"Macrolide antibiotics for bronchiectasis","volume":"3","author":"Kelly","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.jiac.2023.02.015_bib12","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1080\/17512433.2019.1665027","article-title":"A review of antibiotics and psoriasis: induction, exacerbation, and amelioration","volume":"12","author":"Ya-Chu","year":"2019","journal-title":"Expet Rev Clin Pharmacol"},{"key":"10.1016\/j.jiac.2023.02.015_bib13","first-page":"27","article-title":"The clinical effectiveness of long-term azithromycin in patients with chronic generalized periodontitis","volume":"236","author":"Nepokupnaia-Slobodianuk","year":"2014","journal-title":"Georgian Med News"},{"issue":"10","key":"10.1016\/j.jiac.2023.02.015_bib14","first-page":"51e77","article-title":"Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America","volume":"62","author":"Tamar","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jiac.2023.02.015_bib15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jiac.2020.10.010","article-title":"The effectiveness of prescription support and treatment reporting system on the appropriate usage of oral third-generation cephalosporins","volume":"27","author":"Tomoyuki","year":"2021","journal-title":"J Infect Chemother"},{"issue":"5","key":"10.1016\/j.jiac.2023.02.015_bib16","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1197\/jamia.M1299","article-title":"Development of a clinical data Warehouse for hospital infection control","volume":"10","author":"Mary","year":"2003","journal-title":"J Am Med Inf Assoc"},{"issue":"5","key":"10.1016\/j.jiac.2023.02.015_bib17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jiac.2017.12.008","article-title":"The association between erythromycin monotherapy for Mycobacterium avium complex lung disease and cross-resistance to clarithromycin: a retrospective case-series study","volume":"24","author":"Yuki","year":"2018","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2023.02.015_bib18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0022-3565(24)35272-3","article-title":"Anti-inflammatory activity of macrolide antibiotics","volume":"1","author":"Ianaro","year":"2000","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"8","key":"10.1016\/j.jiac.2023.02.015_bib19","article-title":"Global prevalence of non-tuberculous mycobacteria in adults with non-cystic fibrosis bronchiectasis 2006-2021: a systematic review and meta-analysis","volume":"12","author":"Yunchun","year":"2022","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.jiac.2023.02.015_bib20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.anl.2012.09.009","article-title":"Optimal duration of macrolide treatment for chronic sinusitis after endoscopic sinus surgery","volume":"40","author":"Yoshihisa","year":"2013","journal-title":"Auris Nasus Larynx"},{"issue":"7","key":"10.1016\/j.jiac.2023.02.015_bib21","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/lary.27865","article-title":"Factors of success of low-dose macrolides in chronic sinusitis: systematic review and meta-analysis","volume":"129","author":"Kachorn","year":"2019","journal-title":"Laryngoscope"},{"issue":"5","key":"10.1016\/j.jiac.2023.02.015_bib22","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.chest.2018.01.044","article-title":"Clinical and safety outcomes of long-term azithromycin therapy in severe COPD beyond the first year of treatment","volume":"153","author":"Xavier","year":"2018","journal-title":"Chest"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2300051X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2300051X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:05:57Z","timestamp":1761159957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X2300051X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1341321X2300051X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2023.02.015","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-center survey of prescription trends and appropriate use plans for macrolide antimicrobials","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2023.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}